Skip to content
New Era Korea Daily한국어로 보기

Companies

Corporate disclosures, earnings and ownership changes, read from the filings.

Alteogen to absorb biolabs unit in small-scale merger

Alteogen will absorb its 62.9-percent-owned subsidiary Alteogen BioLogics to bring its pipeline and sales operations in-house, issuing 600,477 new shares with a merger date set for Dec. 29.

New Era Daily AI